A
TYRA icon

AlphaQuest’s Tyra Biosciences TYRA Stock Holding History

AlphaQuest’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,139
Closed -$56.2K – 1952
2025
Q4 		$56.2K Sell
2,139
-27,921
-93% -$513K ﹤0.01% 1911
2025
Q3 		$421K Sell
30,060
-43,013
-59% -$490K 0.03% 915
2025
Q2 		$699K Buy
73,073
+43,451
+147% +$413K 0.07% 454
2025
Q1 		$275K Buy
29,622
+24,599
+490% +$318K 0.03% 821
2024
Q4 		$69.8K Sell
5,023
-15,855
-76% -$288K 0.01% 1206
2024
Q3 		$491K Buy
+20,878
New +$438K 0.04% 659

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

AlphaQuest's TYRA Position: Q1 2026 in Review

AlphaQuest sold out of Tyra Biosciences (TYRA) in Q1 2026, closing a stake of 2,139 shares — an estimated $56.2K sold.

AlphaQuest first reported a position in TYRA in Q3 2024 and held it in 6 quarters. The position peaked at $699K in Q2 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • AlphaQuest reported no remaining Tyra Biosciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 2,139 Tyra Biosciences shares in Q1 2026, an estimated $56.2K.
  • AlphaQuest first reported a position in Tyra Biosciences in Q3 2024 and held it in 6 quarters.
  • AlphaQuest's Tyra Biosciences position peaked at $699K in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.